Literature DB >> 18987826

Analysis of methylated circulating DNA in cancer patients' blood.

Eiji Sunami1, Anh-Thu Vu, Sandy L Nguyen, Dave S B Hoon.   

Abstract

Circulating extracellular nucleic acids derived from body fluids such as blood are commonly analyzed to assess malignant diseases. Efficient isolation, extraction, quantification, modification, and analysis methods remain important for utilizing circulating nucleic acids as potential molecular biomarkers. Our refined techniques of DNA isolation from serum, sodium bisulfite modification of extracted DNA, and methylation analysis provide a robust approach for quantitative analysis of circulating tumor-related DNA. The approach allows direct comparison of methylated and nonmethylated genomic sequences in a specimen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18987826     DOI: 10.1007/978-1-59745-522-0_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

Review 1.  Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer.

Authors:  Diego M Marzese; Dave Sb Hoon
Journal:  Expert Rev Mol Diagn       Date:  2015-03-22       Impact factor: 5.225

2.  In Situ Sodium Bisulfite Modification of Genomic DNA from Microdissected Melanoma Paraffin-Embedded Archival Tissues.

Authors:  Diego M Marzese; Sharon K Huang; Dave S B Hoon
Journal:  Methods Mol Biol       Date:  2015-12-13

3.  Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer.

Authors:  Ramin Radpour; Zeinab Barekati; Corina Kohler; Qing Lv; Nicole Bürki; Claude Diesch; Johannes Bitzer; Hong Zheng; Seraina Schmid; Xiao Yan Zhong
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

4.  Transposable hypomethylation is associated with metastatic capacity of primary melanomas.

Authors:  Szilvia I Ecsedi; Hector Hernandez-Vargas; Sheila C Lima; Zdenko Herceg; Roza Adany; Margit Balazs
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

Review 5.  Promoter methylation and the detection of breast cancer.

Authors:  Jennifer Brooks; Paul Cairns; Anne Zeleniuch-Jacquotte
Journal:  Cancer Causes Control       Date:  2009-11       Impact factor: 2.506

Review 6.  Blood biomarkers for uveal melanoma.

Authors:  Pierre L Triozzi; Arun D Singh
Journal:  Future Oncol       Date:  2012-02       Impact factor: 3.674

7.  AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.

Authors:  Sojun Hoshimoto; Christine T Kuo; Kelly K Chong; Teh-Ling Takeshima; Yoshiki Takei; Michelle W Li; Sharon K Huang; Myung-Shin Sim; Donald L Morton; Dave S B Hoon
Journal:  J Invest Dermatol       Date:  2012-03-08       Impact factor: 8.551

Review 8.  The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.

Authors:  Yahya I Elshimali; Husseina Khaddour; Marianna Sarkissyan; Yanyuan Wu; Jaydutt V Vadgama
Journal:  Int J Mol Sci       Date:  2013-09-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.